Abivax (ABVX) Payables (2022 - 2025)
Abivax (ABVX) has 2 years of Payables data on record, last reported at $15.8 million in Q4 2022.
- For Q4 2022, Payables fell 25.63% year-over-year to $15.8 million; the TTM value through Dec 2022 reached $15.8 million, down 25.63%, while the annual FY2022 figure was $16.3 million, 25.73% down from the prior year.
- Payables reached $15.8 million in Q4 2022 per ABVX's latest filing, down from $21.2 million in the prior quarter.
- Across five years, Payables topped out at $21.2 million in Q4 2021 and bottomed at $15.8 million in Q4 2022.